Lamotrigine for Absence Seizures
The effectiveness and safety of lamotrigine (Lamictal) monotherapy in newly diagnosed typical absence seizures in 45 children and adolescents, aged 3-15 years, were evaluated in a placebo-controlled, double-blind trial at centers in Norfolk, VA; Akron, OH; Boston, MA; and Research Triangle Park, NC.
Main Author: | J Gordon Millichap |
---|---|
Format: | Article |
Language: | English |
Published: |
Pediatric Neurology Briefs Publishers
1999-08-01
|
Series: | Pediatric Neurology Briefs |
Subjects: | |
Online Access: | https://www.pediatricneurologybriefs.com/articles/2034 |
Similar Items
-
Multimodal detection of typical absence seizures in home environment with wearable electrodes
by: Christos Chatzichristos, et al.
Published: (2022-10-01) -
Typical Absence Seizures and Related Epilepsy Syndromes
by: Demet KINAY
Published: (2018-12-01) -
EEG phase synchronization during absence seizures
by: Pawel Glaba, et al.
Published: (2023-06-01) -
The effects of hyperventilation on seizure length and cerebral oxygenation during electroconvulsive therapy
by: Oguz Gundogdu, et al.
Published: (2020-05-01) -
Absence seizures in lesion-related epilepsy
by: Xiaoqin Sun, et al.
Published: (2023-09-01)